Advanced Heart Failure and Transplant Cardiology · Norfolk, VA
NPI
1316324288
Since 2015
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
600 Gresham Dr
Norfolk, VA, 23507
Phone (757) 388-3934
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,358 services
Medicare patients, 2024
467
Average age 72
Drug cost, 2024
$5.7M
2,392 prescriptions
Company payments, 2025
$42K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zackary J Tushak was code 99215 (office e&m - established), 307 times for 151 patients. In total Zackary J Tushak billed 1,358 services in 32 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 307 | 151 | $111.93 | $34K |
| 93306 Echocardiography (TTE/TEE) | Facility | 270 | 227 | $51.77 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 136 | 51 | $94.59 | $13K |
| 99291 Critical Care E&M | Facility | 103 | 21 | $169.63 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 82 | 57 | $13.42 | $1,100 |
| 99205 Office E&M - New | Facility | 56 | 56 | $141.73 | $7,937 |
| 99223 Hospital E&M - Initial | Facility | 46 | 39 | $140.06 | $6,443 |
| 99215 Office E&M - Established | Office | 36 | 24 | $102.04 | $3,674 |
| 93264 External Electrocardiographic Monitoring | Facility | 34 | 26 | $21.37 | $726 |
| 93308 Echocardiography (TTE/TEE) | Facility | 33 | 28 | $19.39 | $640 |
| 93325 Echocardiography (TTE/TEE) | Facility | 29 | 24 | $2.40 | $69.52 |
| 93451 Percutaneous Transcatheterization | Facility | 27 | 26 | $100.51 | $2,714 |
| 99152 Anesthesia | Facility | 26 | 25 | $9.44 | $246 |
| 93306 Echocardiography (TTE/TEE) | Office | 26 | 22 | $46.86 | $1,218 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 13 | $24.11 | $506 |
By year: 2022 $15K for 134 services; 2023 $71K for 774 services; 2024 $110K for 1,358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zackary J Tushak prescribed most often to Medicare patients was Spironolactone, with 283 prescriptions and refills. In total Zackary J Tushak wrote 2,392 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 283 | 723 | 105 | $1,759 |
| Jardiance Empagliflozin | 264 | 478 | 66 | $203K |
| Entresto Sacubitril/Valsartan | 239 | 363 | 58 | $223K |
| Metoprolol Succinate Generic | 204 | 486 | 71 | $2,340 |
| Farxiga Dapagliflozin Propanediol | 158 | 269 | 50 | $143K |
| Torsemide Generic | 145 | 321 | 61 | $2,352 |
| Losartan Potassium Generic | 131 | 326 | 50 | $838 |
| Vyndamax Tafamidis | 117 | 129 | 25 | $2.9M |
| Carvedilol Generic | 112 | 265 | 42 | $877 |
| Furosemide Generic | 100 | 248 | 47 | $482 |
| Bumetanide Generic | 49 | 107 | 19 | $1,958 |
| Rosuvastatin Calcium Generic | 43 | 97 | 18 | $448 |
| Atorvastatin Calcium Generic | 42 | 110 | 19 | $380 |
| Vyndaqel Tafamidis Meglumine | 41 | 43 | Under 11 | $961K |
| Eliquis Apixaban | 39 | 55 | Under 11 | $30K |
Brand drugs: 955 claims; generic drugs: 1,437 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zackary J Tushak $42K ($42K in general payments such as food, travel and fees) from 6 companies. The largest payer was Pfizer Inc. with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.